427 Plasma and urinary pharmacokinetics of the novel, oral SHIP1 activator, AQX-1125 in interstitial cystitis/bladder pain syndrome (IC/BPS): Results of the phase2 LEADERSHIP trial

Saved in:
Bibliographic Details
Published in:European urology supplements : official journal of the European Association of Urology 2016-03, Vol.15 (3), p.e427-e427
Main Authors: Nickel, C, Evans, R, Tam, P, Toews, J, MacKenzie, L, Biagi, H, Shrewsbury, S
Format: Article
Language:English
Subjects:
Urology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1569-9056
1878-1500
DOI:10.1016/S1569-9056(16)60429-3